This document contains a protocol that optimizes the experimental design for the evaluation of qualitative tests, to better measure performance and provide a structured data analysis.
The U.S. Food and Drug Administration (FDA) has evaluated and recognized this approved-level consensus guideline for use in satisfying a regulatory requirement.
More Standards PDF
CSA ANSI Z21.69-2002/CSA 6.16-2002
$236.00 $473.00
CSA G401-01 (R2006)
$29.00 $58.00
CSA C22.2 NO. 141-02
$45.00 $90.00
CSA Z245.1-02
$92.00 $184.00